Disclaimer: Investigational Device. Limited by Federal (or United States) to investigational use. Approved for use in Canada only.
The Omnispec Extracorporeal Shock Wave Therapy System
Medispec uses an advanced acoustic technology, known as Erectile Dysfunction Shock Wave Therapy (EDSWT) to non-invasively treat vasculogenic ED. This technology has been proven to be effective in cardiology, with recent success in ischemic tissues of the heart. Using the same modularity as in the heart, the Omnispec Extracorporeal Shock Wave Therapy System, ED1000TM uses low-intensity extracorporeal shock waves to focus on the blood vessels to encourage neovascularization in the penis shaft and crus. This treatment may help to relieve vascular deficiency – the common cause of erectile dysfunction.
EDSWT employs single-pulse acoustic waves similar to ultrasound waves, which are generated by an underwater high-voltage spark. These shock waves are focused directly on the patient’s skin near the target area.
Unlike conventional treatments, such as PDE5 inhibitors, EDSWT does not involve the use of pharmaceuticals. The Omnispec Extracorporeal Shock Wave Therapy System, ED1000TM is a 20 minute procedure, which can be performed in any out-patient or clinical setting and requires no anesthesia or sedation. Its compact, straight forward design makes it easy to use, maintain and store.
|Patients||Physicians||U.S. Research Center||Canadian Customers|